Riviciclib

• Description :

  A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  438.3

• Molecular Formula :

  C21H20ClNO5.HCl

• Notes :

  Research use only, not for human use.

• Receptor :

  CDK1/CyclinB| CDK2/CyclinA| CDK4/CyclinD1| CDK6/CyclinD3| CDK9/CyclinT1

• CAS Number :

  920113-03-7